Han Jing, Zhang Chunye, Gu Ting, Yang Xi, Hu Longwei, Tian Zhen, Li Jiang, Zhang Chenping
Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China.
Department of Oral Pathology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China.
Oncol Lett. 2019 Mar;17(3):2915-2922. doi: 10.3892/ol.2019.9935. Epub 2019 Jan 15.
Recent studies have indicated that a recurrent t(6;9)(q22-23;p23-24) chromosomal translocation in salivary adenoid cystic carcinoma (ACC) results in a MYB proto-oncogene transcription factor-nuclear factor I/B gene fusion, which has not previously been detected in any non-ACC carcinomas of the head and neck. In the present study, data on clinical factors affecting the survival rate of patients with salivary ACC from a single institution was retrospectively analyzed, and the frequency of gene rearrangement determined. A total of 97 patient cases were analyzed, and young adults presenting with ACC (<40 years old) accounted for 19.6% of all patients (n=19). A total of 70.1% (n=68) displayed neurological symptoms, including pain, paraesthesia, tongue deviation, and facial paralysis. A marked majority of the analyzed tumors (85.6%) displayed evidence of rearrangement. rearrangement was significantly higher in patients with late Tumor-Node-Metastasis (TNM) stage cancer compared with that in patients with early TNM stage (P=0.033), as detected by a dual color break-apart fluorescence hybridization probe. Kaplan-Meier analysis revealed significant differences in patient overall survival (OS) time with regard to age, gender, TNM stage, neurological symptoms, margin status and rearrangement. Specifically, young age was significantly associated with a shorter OS time. In summary, the present study suggested that young patients with salivary ACC presented with a worse prognosis, in contrast to the majority of patients with salivary ACC. Moreover, alterations exhibited a high positive rate in salivary ACC, and therefore, the absence of rearrangements may be associated with a better prognosis.
近期研究表明,涎腺腺样囊性癌(ACC)中反复出现的t(6;9)(q22 - 23;p23 - 24)染色体易位会导致MYB原癌基因转录因子与核因子I/B基因融合,此前在任何头颈部非ACC癌中均未检测到这种情况。在本研究中,回顾性分析了来自单一机构的影响涎腺ACC患者生存率的临床因素数据,并确定了基因重排的频率。共分析了97例患者病例,其中患有ACC的年轻成年人(<40岁)占所有患者的19.6%(n = 19)。共有70.1%(n = 68)表现出神经症状,包括疼痛、感觉异常、舌偏斜和面瘫。绝大多数分析的肿瘤(85.6%)显示出重排证据。通过双色断裂分离荧光杂交探针检测发现,晚期肿瘤-淋巴结-转移(TNM)分期癌症患者的重排比早期TNM分期患者显著更高(P = 0.033)。Kaplan-Meier分析显示,患者的总生存期(OS)在年龄、性别、TNM分期、神经症状、切缘状态和重排方面存在显著差异。具体而言,年轻与较短的OS时间显著相关。总之,本研究表明,与大多数涎腺ACC患者相比,年轻的涎腺ACC患者预后较差。此外,重排在涎腺ACC中呈现出较高的阳性率,因此,未发生重排可能与较好的预后相关。